The key risks across both compounds include: Gastrointestinal adverse events (nausea, vomiting, diarrhoea), most pronounced during dose escalation Potential for gallbladder disease, consistent with rapid weight reduction Retatrutide-specific: dysesthesia and elevated resting heart rate [3] Both compounds: risk of hypoglycaemia when used in combination with insulin or sulphonylureas in diabetic models All compounds available through Sempica are strictly for research use by qualified professionals
GIP supports metabolic function through a complementary pathway
The nose-anus length was assessed to determine body growth
Health-E Commerce Expands Telehealth Weight Loss Options with MEDVI and Remedy Meds HEC Team Oct 20, 2025 3 min read New arrangement with Forbes Health will make medically backed solutions from MEDVi and Remedy Meds available on FSA Store and HSA Store DALLAS (October 21, 2025) - Health-E Commerce, the parent brand to FSA Store and HSA Store , the first and leading online stores dedicated to selling only products and services that are considered eligible for flexible spending accounts (FSAs) and health savings accounts (HSAs), today announced that it has expanded the selection of trusted weight loss medications available to people who shop at FSA Store and HSA Store
doi: 10.1146/annurev.physiol.70.113006.100506 165 SternsonSMEiseltAK
In addition to these findings on atherosclerotic plaque formation, GLP-1R agonists prevented the increase in plasminogen activator inhibitor type-1 (PAI-1) and vascular cell adhesion molecule-1 (VCAM-1) gene expression in response to TNF- or hyperglycemia in HUVEC through PKA pathway [24],[70]